Prestigious Prize Honors Pioneering Body's Defenses Research

This year's Nobel Prize in medical science has been granted for revolutionary discoveries that illuminate how the body's defense network targets harmful pathogens while sparing the body's own cells.

Three esteemed scientists—from Japan Prof. Sakaguchi and US experts Mary Brunkow and Dr. Ramsdell—received this honor.

The work identified specialized "security guards" within the immune system that eliminate malfunctioning immune cells that could attacking the organism.

These discoveries are now paving the way for innovative treatments for autoimmune diseases and malignancies.

These laureates will share a monetary award worth 11 million SEK.

Crucial Discoveries

"The research has been decisive for understanding how the body's defenses operates and the reason we don't all suffer from severe autoimmune diseases," commented the head of the award panel.

This team's research address a core mystery: In what way does the immune system protect us from countless invaders while leaving our healthy cells unharmed?

Our body's protection system employs white blood cells that scan for indicators of disease, including viruses and germs it has not met before.

These defenders utilize detectors—known as recognition units—that are generated randomly in a vast number of combinations.

This provides the defense network the ability to fight a wide array of threats, but the randomness of the mechanism unavoidably produces white blood cells that may target the body.

Security Guards of the Body

Researchers earlier knew that some of these harmful white blood cells were eliminated in the thymus—the site where immune cells develop.

This year's award honors the discovery of regulatory T-cells—described as the body's "peacekeepers"—which patrol the system to disarm other immune cells that assault the healthy cells.

It is known that this mechanism malfunctions in self-attack conditions such as type-1 diabetes, multiple sclerosis, and rheumatoid arthritis.

The prize committee stated, "These discoveries have laid the foundation for a novel area of investigation and spurred the creation of new treatments, for example for tumors and autoimmune diseases."

Regarding malignancies, T-regs prevent the body from attacking the growth, so studies are focused on reducing their numbers.

In autoimmune diseases, trials are exploring increasing regulatory T-cells so the organism is no longer being harmed. A comparable method could also be useful in minimizing the risks of transplanted organ rejection.

Pioneering Experiments

Prof Shimon Sakaguchi, of a Japanese institution, conducted experiments on rodents that had their immune gland extracted, causing self-attack conditions.

He demonstrated that injecting immune cells from other mice could prevent the illness—implying there was a system for blocking immune cells from attacking the host.

Dr. Brunkow, from the a research center in a US city, and Dr. Ramsdell, currently at a biotech firm in San Francisco, were studying an inherited immune disorder in mice and people that led to the identification of a genetic factor critical for the way regulatory T-cells operate.

"The groundbreaking work has uncovered how the immune system is kept in check by T-reg cells, preventing it from mistakenly targeting the healthy cells," commented a prominent physiology expert.

"This research is a remarkable illustration of how basic physiological study can have broad consequences for public health."